Response of CD44+/CD24-/low breast cancer stem/progenitor cells to tamoxifen-and doxorubicin-induced autophagy

International Journal of Molecular Medicine

Volumn 31, Issue 6, 2013, Pages 1477-1483

  Yenigun, Vildan Betul ^a   Ozpolat, Bulent ^b   Torun Kose, Gamze ^a  

^a YEDITEPE UNIVERSITY   (Turkey)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Apoptosis; Autophagy; Breast cancer stem cells; Doxorubicin; Tamoxifen

Indexed keywords

CD24 ANTIGEN; DOXORUBICIN; HERMES ANTIGEN; TAMOXIFEN;

APOPTOSIS; ARTICLE; AUTOPHAGY; BREAST CANCER; CANCER STEM CELL; CELL GROWTH; CELL ISOLATION; CELL PROLIFERATION; CELL STRAIN MCF 7; DRUG MECHANISM; FLOW CYTOMETRY; IC 50; PRIORITY JOURNAL; RELATIVE DENSITY; WESTERN BLOTTING;

ANTIGENS, CD24; ANTIGENS, CD44; APOPTOSIS; AUTOPHAGY; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; DOXORUBICIN; FEMALE; HUMANS; INHIBITORY CONCENTRATION 50; MCF-7 CELLS; NEOPLASTIC STEM CELLS; TAMOXIFEN;

EID: 84876371206     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2013.1342     Document Type: Article

References (32)

1. Gustafsson JA: Novel aspects of estrogen action. J Soc Gynecol Investig 7 (Suppl 1): S8-S9, 2000.
2. Moggs JG and Orphanides G: Estrogen receptors: orchestrators of pleiotropic cellular responses. EMBO Rep 2: 775-781, 2001. (Pubitemid 32982744)
3. Cos S, González A, Martínez-Campa C, Mediavilla MD, Alonso-González C and Sánchez-Barceló EJ: Estrogen-signaling pathway: a link between breast cancer and melatonin oncostatic actions. Cancer Detect Prev 30: 118-128, 2006. (Pubitemid 43766230)
4. Fornari FA, Randolph JK, Yalowich JC, Ritke MK and Gewirtz DA: Interference by doxorubicin with DNA unwinding in MCF-7 breast tumor cells. Mol Pharmacol 45: 649-656, 1994. (Pubitemid 24139191)
5. Akar U, Chaves-Reyez A, Barria M, Tari A, Sanguino A, Kondo Y, Kondo S, Arun B, Lopez-Berestein G and Ozpolat B: Silencing of Bcl-2 expression by small interfering RNA induces autophagic cell death in MCF-7 breast cancer cells. Autophagy 4: 669-679, 2008.
6. Deroo BJ and Korach KS: Estrogen receptors and human disease. J Clin Invest 116: 561-570, 2006. (Pubitemid 43326860)
7. Shang Y, Hu X, DiRenzo J, Lazar MA and Brown M: Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 103: 843-852, 2000.
8. Bursch W, Ellinger A, Kienzl H, Török L, Pandey S, Sikorska M, Walker R and Hermann RS: Active cell death induced by the anti-estrogens tamoxifen and ICI 164 384 in human mammary carcinoma cells (MCF-7) in culture: the role of autophagy. Carcinogenesis 17: 1595-1607, 1996. (Pubitemid 26280381)
9. Paglin S, Hollister T, Delohery T, Hackett N, McMahill M, Sphicas E, Domingo D and Yahalom J: A novel response of cancer cells to radiation involves autophagy and formation of acidic vesicles. Cancer Res 61: 439-444, 2001. (Pubitemid 32128593)
10. Charafe-Jauffret E, Ginestier C and Birnbaum D: Breast cancer stem cells: tools and models to rely on. BMC Cancer 9: 202, 2009.
11. Wang Y, Yang J, Zheng H, Tomasek GJ, Zhang P, McKeever PE, Lee EY and Zhu Y: Expression of mutant p53 proteins implicates a lineage relationship between neural stem cells and malignant astrocytic glioma in a murine model. Cancer Cell 15: 514-526, 2009.
12. Santisteban M, Reiman JM, Asiedu MK, Behrens MD, Nassar A, Kalli KR, Haluska P, Ingle JN, Hartmann LC, Manjili MH, Radisky DC, Ferrone S and Knutson KL: Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells. Cancer Res 69: 2887-2895, 2009.
13. Charafe-Jauffret E, Monville F, Ginestier C, Dontu G, Birnbaum D and Wicha MS: Cancer stem cells in breast: current opinion and future challenges. Pathobiology 75: 75-84, 2008. (Pubitemid 351820725)
14. Dean M, Fojo T and Bates S: Tumour stem cells and drug resistance. Nat Rev Cancer 5: 275-284, 2005. (Pubitemid 40488633)
15. Zhou S, Schuetz JD, Bunting KD, Colapietro AM, Sampath J, Morris JJ, Lagutina I, Grosveld GC, Osawa M, Nakauchi H and Sorrentino BP: The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med 7: 1028-1034, 2001. (Pubitemid 32937383)
16. Hait WN and Yang JM: Clinical management of recurrent breast cancer: development of multidrug resistance (MDR) and strategies to circumvent it. Semin Oncol 32 (Suppl 7): S16-S21, 2005. (Pubitemid 41785442)
17. Wolman SR, Heppner GH and Wolman E: New directions in breast cancer research. FASEB J 11: 535-543, 1997. (Pubitemid 27274427)
18. Ponti D, Costa A, Zaffaroni N, Pratesi G, Petrangolini G, Coradini D, Pilotti S, Pierotti MA and Daidone MG: Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res 65: 5506-5511, 2005. (Pubitemid 40911148)
19. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ and Clarke MF: Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100: 3983-3988, 2003. (Pubitemid 36418143)
20. Yorimitsu T and Klionsky DJ: Autophagy: molecular machinery for self-eating. Cell Death Differ 12 (Supp 2): S1542-S1552, 2005.
21. Shintani T and Klionsky DJ: Autophagy in health and disease: a double-edged sword. Science 306: 990-995, 2004. (Pubitemid 39482894)
22. Ravikumar B, Moreau K, Jahreiss L, Puri C and Rubinsztein DC: Plasma membrane contributes to the formation of pre-autophagosomal structures. Nat Cell Biol 12: 747-757, 2010.
23. Abedin MJ, Wang D, McDonnell MA, Lehmann U and Kelekar A: Autophagy delays apoptotic death in breast cancer cells following DNA damage. Cell Death Differ 14: 500-510, 2007.
24. Codogno P and Meijer AJ: Autophagy and signaling: their role in cell survival and cell death. Cell Death Differ 12: 1509-1518, 2005. (Pubitemid 41553987)
25. Lum JJ, Bauer DE, Kong M, Harris MH, Li C, Lindsten T and Thompson CB: Growth factor regulation of autophagy and cell survival in the absence of apoptosis. Cell 120: 237-248, 2005. (Pubitemid 40174766)
26. Beau I, Mehrpour M and Codogno P: Autophagosomes and human diseases. Int J Biochem Cell Biol 43: 460-464, 2011.
27. Schneider L and Zhang J: Lysosomal function in macromolecular homeostasis and bioenergetics in Parkinson's disease. Mol Neurodegener: Apr 13, 2010 (Epub ahead of print). doi: 10.1186/1750-1326-5-14.
28. Weissman IL, Anderson DJ and Gage F: Stem and progenitor cells: origins, phenotypes, lineage commitments, and transdifferentiations. Annu Rev Cell Dev Biol 17: 387-403, 2001. (Pubitemid 33096181)
29. Wright MH, Calcagno AM, Salcido CD, Carlson MD, Ambudkar SV and Varticovski L: Brca1 breast tumors contain distinct CD44+/CD24-and CD133+ cells with cancer stem cell characteristics. Breast Cancer Res 10: R10, 2008.
30. Fillmore CM and Kuperwasser C: Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy. Breast Cancer Res 10: R25, 2008.
31. Kim HJ, Kim JB, Lee KM, Shin I, Han W, Ko E, Bae JY and Noh DY: Isolation of CD24high and CD24low/- cells from MCF-7: CD24 expression is positively related with proliferation, adhesion and invasion in MCF-7. Cancer Lett 258: 98-108, 2007. (Pubitemid 47600499)
32. Li X, Lewis MT, Huang J, Gutierrez C, Osborne CK, Wu MF, Hilsenbeck SG, Pavlick A, Zhang X, Chamness GC, Wong H, Rosen J and Chang JC: Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. J Natl Cancer Inst 100: 672-679, 2008.